Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Human Schwann Cell (ahSC) augmentation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Human Schwann Cell (ahSC) augmentation, covering 2025-09-02 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI) [Phase 1]

See pricing